Ornovi, Inc.
🇺🇸United States
A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects
Phase 1
Withdrawn
- Conditions
- Alopecia Areata
- Interventions
- Drug: OR-101 (Single ascending dose)Drug: OR-101 (Food effect)Drug: OR-101 (Multiple ascending dose)Drug: Placebo
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Ornovi, Inc.
- Registration Number
- NCT06045624
- Locations
- 🇦🇺
SCIENTIA Clinical Research Ltd, Randwick, New South Wales, Australia
© Copyright 2025. All Rights Reserved by MedPath